Futility in the paediatric cardiac ICU

Michael P Fundora1, Zahidee Rodriguez1, William T Mahle1

  • 1Children's Healthcare of Atlanta, Department of Pediatrics, Division of Cardiology, Emory University, Atlanta, GA, USA.

Insights

Futile care occurred in 25% of long-stay pediatric cardiac ICU deaths, with no economic impact. Cultural factors influenced end-of-life decisions, with Black families less likely to withdraw life support and Hispanic families more likely to continue futile care.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Health Services Research

Background:

  • Studies indicate 5-20% of pediatric ICU patients may receive futile care.
  • No prior data exists on futile care prevalence in Pediatric Cardiac ICUs.
  • This study addresses the prevalence and economic impact of futile care in this specific population.

Purpose of the Study:

  • To determine the prevalence of futile care in pediatric cardiac intensive care units (ICUs).
  • To assess the economic impact of futile care in pediatric cardiac ICUs.
  • To identify demographic and cultural factors associated with futile care and end-of-life decisions.

Main Methods:

  • Retrospective cohort study of congenital cardiac disease patients (0-21 years) with >30 days length of stay who died between 2015-2018.
  • Independent retrospective review of medical team documentation of futility.
  • Analysis of demographic and socioeconomic factors of families.

Main Results:

  • Of 127 deaths, 51 (40%) had prolonged hospitalization (>30 days).
  • Futile care was identified in 13 patients (25% of prolonged stays), comprising 0.69% of total patient days with no significant difference in charges.
  • Black families were less likely to elect withdrawal of life-sustaining treatment (p=0.01), and Hispanic families were more likely to continue futile care (p=0.044).

Conclusions:

  • This is the first study to examine futile care in the pediatric cardiac ICU.
  • Cultural factors appear to influence end-of-life decisions, with observed disparities among racial and ethnic groups.
  • Futile care had a minimal resource burden, highlighting the need to investigate cultural factors to support families.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
156
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
293
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
196
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
175
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
205